Uncategorized - December 18, 2020
Top Norwegian biotech news 2020
Oslo Cancer Cluster has highlighted ten of their Norwegian members who caught their attention this year. Despite the challenges with the corona pandemic, several of Oslo Cancer Cluster’s members have distinguished themselves with good news and positive updates throughout the year. “The corona pandemic made 2020 a challenging year for many companies, but the health […]
Business Award - November 27, 2020
Agnete Fredriksen receives the Research Council of Norway’s innovation award
The Research Council has announced that the innovation award goes to founder and scientific director Agnete Fredriksen in Vaccibody. The innovation award will honor research-based innovation. Anne Kjersti Fahlvik, Area Director for Business Development and Innovation at the Research Council, justifies the award with “Vaccibody is a unique example of how the combination of talent, […]
Column - November 17, 2020
The new frontier in cancer innovation
Oslo Cancer Cluster (OCC) Innovation Park and Incubator plans to expand by 50 000 m2 in the coming years. The goal is to create an international innovation hub in cancer. Why? Because personalized medicine is changing cancer innovation. The Norwegian Prime Minister Erna Solberg had great expectations when she opened OCC Innovation Park in July […]
Uncategorized - October 15, 2020
Norwegian government increases funding for personalized medicine
In the newly released state budget, the government also announces funds for clinical trials, mature clusters and digitalization. The Norwegian government increases the funding for personalized medicine with NOK 30 million to a total of NOK 61.3 million. NOK 25 million will be used to establish precision diagnostics with advanced molecular profiling in the hospitals, […]
Uncategorized - August 20, 2020
Oslo Cancer Cluster becomes a member of Oslo Science City
Oslo Science City is the first innovation district in Norway with the ambition to contribute to research excellence, jobs creation, the green shift and sustainable economic development. “We intend to develop a vibrant city area where people meet to innovate and explore what we still don’t understand,” says Christine Wergeland Sørbye, CEO of Oslo Science […]
Financing - July 31, 2020
Exact Therapeutics raises 155 million NOK and lists on Oslo Stock Exchange’s Merkur Market
Exact Therapeutics announces that its shares have been admitted to trading on Oslo Stock Exchange’s Merkur Market under the ticker EXTX-ME with first day of trading 14 July 2020, following the successful completion of a NOK 155 million private placement. Following a bookbuilding period from 4 – 16 June 2020, the company has raised NOK […]
